Killing Cancer At Its Stem Cell Origin

Killing Cancer At Its Stem Cell Origin

Killing Cancer When it comes to killing cancer, eradicating every single cell is the goal. But did you know there are different kinds of cancer cells? One specific type, called cancer stem cells (CSC), is catching the eye of drug developers. Discovered more than a...
The Emerging Proteomics Market

The Emerging Proteomics Market

Picking Apart The Protein Genomics continues to be all the rage in biotech circles—with special kudos to Illumina’s (San Diego, CA) recent ability to obtain an entire human genome sequence in 24-hours for a mere thousand dollars. Our overall understanding of...

Therascreen: New Companion Diagnostic

NEW COMPANION DIAGNOSTIC APPROVAL Colorectal cancer is the third most common cancer found in both men and women in the U.S., and is the second leading cause of cancer deaths. Approximately 1.2 million cases of colorectal cancer are expected to occur globally. Just...